The past, present, and future of allergic diseases in China

Abstract

The past, present, and future of allergic diseases in ChinaAllergic diseases have become a global health problem and pose a significant burden on healthcare resources due to their increasing prevalence, severity, chronic nature, and associated management cost. If the current increasing trend continues, it is expected that allergic diseases will reach 4 billion cases worldwide by the 2050s. 1,2 Currently, approximately 30%-40% of the global population suffers from some form of allergies, and an increasing trend in the prevalence of various allergic diseases has been reported in China in recent years. 3 A national cross-sectional China Pulmonary Health study reported that the overall prevalence of asthma was 4.2%, and a 6-year period survey based on 18 major cities found that the prevalence of self-reported allergic rhinitis (AR) was 17.6%. 4 Furthermore, another multi-center study demonstrated that the overall prevalence of selfreported AR and physician-diagnosed AR was 32.4% and 18.5%, respectively, in the northern grassland region of China. 5 Zheng et al.

PM2.5 chemical constituents and allergic rhinitis: Findings from a prospective cohort study in China

“…To the Editor, Allergic rhinitis, with an increasing prevalence worldwide from <1% in the 1920s to 10%-40% nowadays, has caused a low quality of life, a loss of productivity, considerable economic burdens, and severe morbidity. 1 Exposure to PM 2.5 has been positively associated with the prevalence of allergic rhinitis. 2 However, PM 2.5 is variable in chemical composition and little is known about its effects on allergic rhinitis.…”

“…Peng Jia 1,2,3,4 Chuanteng Feng 5,6 Tingting Ye 5 Ying Shao 7 Shujuan Yang 4,5,8 1 School of Resource and Environmental Sciences, Wuhan University, Wuhan, China 2 Hubei Luojia Laboratory, Wuhan, China…”

Genetic associations between gut microbiota and allergic rhinitis: an LDSC and MR analysis

“…Allergic rhinitis (AR) affects a significant portion of the global population, with variable prevalence across different regions. Recent surveys in China, for example, report a self-reported AR prevalence of 17.6%, highlighting its substantial impact on public health (Zhang and Akdis, 2022). The symptoms of AR include nasal congestion, watery eyes, rhinorrhea (runny nose), and non-nose/eye symptoms such as itching and sneezing, which significantly impair the quality of life of affected individuals (Li et al, 2022).…”